Z. BAHAT And G. Bahat, "Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy," FRONTIERS IN ONCOLOGY , vol.11, 2022
BAHAT, Z. And Bahat, G. 2022. Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy. FRONTIERS IN ONCOLOGY , vol.11 .
BAHAT, Z., & Bahat, G., (2022). Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy. FRONTIERS IN ONCOLOGY , vol.11.
BAHAT, ZÜMRÜT, And Gülistan BAHAT-ÖZTÜRK. "Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy," FRONTIERS IN ONCOLOGY , vol.11, 2022
BAHAT, ZÜMRÜT And Bahat, Gülistan. "Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy." FRONTIERS IN ONCOLOGY , vol.11, 2022
BAHAT, Z. And Bahat, G. (2022) . "Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy." FRONTIERS IN ONCOLOGY , vol.11.
@article{article, author={ZÜMRÜT BAHAT And author={Gülistan BAHAT-ÖZTÜRK}, title={Commentary: Association of Sarcopenia with Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy}, journal={FRONTIERS IN ONCOLOGY}, year=2022}